OLIDIA referências disponíveis na ALLPARA para uso profissional, de origem direta e certificadas em cada envio.
Olidia 120
Olidia 120 is an injectable, sterile absorbable poly-L-lactic acid (PLLA) dermal filler by PRP Life Science Co., Ltd. in South Korea, developed to temporarily improve moderate to severe nasolabial folds. It is suitable for practitioners treating these folds, with injection into the deep dermis or the subcutaneous (subdermal) layer. Each vial contains PLLA with carboxymethylcellulose (CMC) and mannitol at a total dose of 121.7 mg, and the product is intended for professional use.
Principais vantagens de Olidia 120
- Improves moderate to severe nasolabial folds
- PLLA-based formulation designed for a gradual tissue response after injection
- For professional injection into the deep dermis or subdermal layer
- CE-marked medical device (CE 1434)
Indicações e utilização profissional
Principais indicações
- Moderate to severe nasolabial folds
Utilização profissional
For professional use only, by trained physicians. Olidia 120 is administered by injection into the deep dermis or subdermal layer to temporarily improve moderate to severe nasolabial folds. Ensure the product is sterile before use and check the expiration date on the product label. Explain the indications, contraindications, and potential side effects to the patient prior to treatment. Avoid areas where vascular occlusion may occur; injection into blood vessels may cause serious effects including blindness, so avoid areas of thin skin and high vascularity such as the glabella and periorbital areas. Do not inject into the vermilion of the lips; safety and efficacy for lip augmentation are not established.
Zonas de tratamento
- Moderate to severe nasolabial folds.
Perfil do paciente
Do not use until any infection or inflammation at or near the injection site is resolved. Do not use in patients hypersensitive to the product or its components. Safety has not been established in patients susceptible to keloids, hyperpigmentation, or hypertrophic scarring. In patients with a history of herpetic eruption, injection may trigger recurrence.
Como funciona Olidia 120
Olidia 120 works through poly-L-lactic acid (PLLA) combined with carboxymethylcellulose and mannitol. Injected into the deep dermis or subdermal layer, the PLLA stimulates a gradual tissue response to temporarily improve moderate to severe nasolabial folds.
Porquê encomendar na Allpara
A Allpara oferece produtos OLIDIA originais e verificados de fornecedores selecionados, com rastreabilidade total dos lotes e apoio especializado. Servimos clínicas e profissionais de estética com produtos com certificação CE, entrega rápida em toda a UE a partir do nosso armazém na UE e preços profissionais competitivos. A nossa prioridade é a segurança, a satisfação e os resultados dos seus pacientes, com apoio pós-venda dedicado para a sua tranquilidade.
Perguntas frequentes
What is Olidia 120 used for?
Olidia 120 is used to temporarily improve moderate to severe nasolabial folds.
What is in the Olidia 120 formula?
Olidia 120 contains poly-L-lactic acid (PLLA) with carboxymethylcellulose (CMC) and mannitol, at a total dose of 121.7 mg per vial.
Where is Olidia 120 injected?
Olidia 120 is injected into the deep dermis or subdermal layer.
Mais de PRP Life Science
Alternativas para a clínica
Retome onde ficou
Olidia 120
Olidia 120 is an injectable, sterile absorbable poly-L-lactic acid (PLLA) dermal filler by PRP Life Science Co., Ltd. in South Korea, developed to temporarily improve moderate to severe nasolabial folds. It is suitable for practitioners treating these folds, with injection into the deep dermis or the subcutaneous (subdermal) layer. Each vial contains PLLA with carboxymethylcellulose (CMC) and mannitol at a total dose of 121.7 mg, and the product is intended for professional use.
Principais vantagens de Olidia 120
- Improves moderate to severe nasolabial folds
- PLLA-based formulation designed for a gradual tissue response after injection
- For professional injection into the deep dermis or subdermal layer
- CE-marked medical device (CE 1434)
Indicações e utilização profissional
Principais indicações
- Moderate to severe nasolabial folds
Utilização profissional
For professional use only, by trained physicians. Olidia 120 is administered by injection into the deep dermis or subdermal layer to temporarily improve moderate to severe nasolabial folds. Ensure the product is sterile before use and check the expiration date on the product label. Explain the indications, contraindications, and potential side effects to the patient prior to treatment. Avoid areas where vascular occlusion may occur; injection into blood vessels may cause serious effects including blindness, so avoid areas of thin skin and high vascularity such as the glabella and periorbital areas. Do not inject into the vermilion of the lips; safety and efficacy for lip augmentation are not established.
Zonas de tratamento
- Moderate to severe nasolabial folds.
Perfil do paciente
Do not use until any infection or inflammation at or near the injection site is resolved. Do not use in patients hypersensitive to the product or its components. Safety has not been established in patients susceptible to keloids, hyperpigmentation, or hypertrophic scarring. In patients with a history of herpetic eruption, injection may trigger recurrence.
Como funciona Olidia 120
Olidia 120 works through poly-L-lactic acid (PLLA) combined with carboxymethylcellulose and mannitol. Injected into the deep dermis or subdermal layer, the PLLA stimulates a gradual tissue response to temporarily improve moderate to severe nasolabial folds.
Porquê encomendar na Allpara
A Allpara oferece produtos OLIDIA originais e verificados, com rastreabilidade total dos lotes, stock com certificação CE, entrega rápida em toda a UE e apoio pós-venda especializado.
Perguntas frequentes
What is Olidia 120 used for?
Olidia 120 is used to temporarily improve moderate to severe nasolabial folds.
What is in the Olidia 120 formula?
Olidia 120 contains poly-L-lactic acid (PLLA) with carboxymethylcellulose (CMC) and mannitol, at a total dose of 121.7 mg per vial.
Where is Olidia 120 injected?
Olidia 120 is injected into the deep dermis or subdermal layer.